Regeneron Pharmaceuticals
(REGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,617,800 | 1,467,700 | 812,700 | 535,203 | 809,102 |
| Marketable Securities | 1,596,500 | 1,342,200 | 596,800 | 503,481 | 236,121 |
| Receivables | 2,785,600 | 2,243,200 | 1,974,300 | 1,611,620 | 1,467,793 |
| Inventories | 1,415,500 | 1,151,200 | 726,100 | 399,356 | 238,578 |
| TOTAL | $7,689,100 | $6,447,600 | $4,335,000 | $3,180,188 | $2,915,095 |
| Non-Current Assets | |||||
| PPE Net | 2,890,400 | 2,575,800 | 2,358,600 | 2,083,421 | 1,594,120 |
| Investments And Advances | 3,256,800 | 1,755,000 | 1,486,500 | 864,260 | 632,162 |
| Other Non-Current Assets | 968,901 | 956,100 | 584,200 | 845,597 | 467,755 |
| TOTAL | $7,116,101 | $5,286,900 | $4,429,300 | $3,793,278 | $2,694,037 |
| Total Assets | $14,805,200 | $11,734,500 | $8,764,300 | $6,973,466 | $5,609,132 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 418,100 | 218,200 | 178,200 | 879,096 | 644,112 |
| Other current liabilities | 1,296,400 | 772,100 | 637,200 | 1,178 | 13,563 |
| TOTAL | $2,096,600 | $1,442,800 | $1,135,500 | $1,241,495 | $811,162 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 382,100 | 452,500 | 320,100 | 231,664 | 153,487 |
| Other Non-Current Liabilities | 799,700 | 361,700 | 152,000 | 100,385 | 115,535 |
| TOTAL | $1,618,900 | $1,534,400 | $1,484,700 | $1,282,726 | $1,143,133 |
| Total Liabilities | $3,715,500 | $2,977,200 | $2,620,200 | $2,524,221 | $1,954,295 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 110,020 | 109,277 | 107,697 | 106,081 | 104,788 |
| Common Shares | 100 | 100 | 100 | 110 | 108 |
| Retained earnings | 7,379,800 | 5,254,300 | 2,946,700 | 1,748,222 | 852,700 |
| Other shareholders' equity | 21,200 | -12,700 | 400 | -13,080 | 8,503 |
| TOTAL | $11,089,700 | $8,757,300 | $6,144,100 | $4,449,245 | $3,654,837 |
| Total Liabilities And Equity | $14,805,200 | $11,734,500 | $8,764,300 | $6,973,466 | $5,609,132 |